Kim, D., Chung, H., Liu, W., Jeong, K., Ozmen, T. Y., Ozmen, F., . . . Lackner, M. R. Cyclin E1/CDK2 activation defines a key vulnerability to WEE1 kinase inhibition in gynecological cancers. Nature Portfolio.
Chicago Style (17th ed.) CitationKim, Daehwan, et al. Cyclin E1/CDK2 Activation Defines a Key Vulnerability to WEE1 Kinase Inhibition in Gynecological Cancers. Nature Portfolio.
MLA (9th ed.) CitationKim, Daehwan, et al. Cyclin E1/CDK2 Activation Defines a Key Vulnerability to WEE1 Kinase Inhibition in Gynecological Cancers. Nature Portfolio.
Warning: These citations may not always be 100% accurate.